Get Ready For Super Shedders
Opinion — By The News Watchmen
This week, the FDA handed Moderna exactly what it wanted: approval of an mRNA flu shot for Americans aged 50 and older. Moderna’s mFLUSIVA is the first mRNA-based seasonal influenza vaccine approved in the United States. The approval covers adults 50 and older, with the approval for those 65 and above granted through the accelerated-approval pathway. The corporate press will call it a breakthrough. I call it a declaration of biological war. Zero day is coming, and almost nobody is prepared.
Zero day is a term borrowed from cybersecurity: an unpatched vulnerability. Here, the vulnerability is your family’s health, and the patch being sold to you is itself the weapon. I’ve been warning for years that mRNA shots do not behave like traditional vaccines. They are genetic instruction systems designed to cause cells to produce a targeted protein and generate an immune response. Now that technology is being put into a seasonal influenza vaccine for millions of older Americans, and that raises legitimate questions about safety, long-term effects, and what happens when a new vaccine platform moves from COVID-19 into another major respiratory disease.
The most controversial question is whether vaccinated people can somehow expose others through vaccine-related shedding. That claim remains disputed and has not been established for injected mRNA vaccines. But critics of the technology argue that regulators and manufacturers should be required to answer the question publicly and transparently before the technology becomes widespread.
The FDA Just Approved It — But What Exactly Does It Prevent?
Read the approval language carefully. The FDA’s approval is for prevention of seasonal influenza disease. The agency did not simply declare that the product makes a person incapable of becoming infected or transmitting influenza under every circumstance. In fact, Moderna’s pivotal trial involved more than 40,000 participants and found mFLUSIVA was more effective than the comparator vaccine at preventing laboratory-confirmed influenza in the studied population.
That distinction matters.
A vaccine can be approved for prevention of disease without guaranteeing that no vaccinated person will ever become infected or transmit a respiratory virus. The question critics should be asking is not whether regulators can produce favorable numbers. The question is whether the public is being given the complete picture about effectiveness, adverse events, limitations, and long-term surveillance.
That is where skepticism becomes reasonable.
The approval of a new mRNA platform for influenza represents another major expansion of a technology that only recently became widely used. The FDA has granted traditional approval for adults 50–64 and accelerated approval for adults 65 and older, with additional postmarketing data required for the latter group.
For those who remain skeptical after the COVID-19 experience, that alone is enough reason to demand answers.
The Word Games: What Does “Influenza Disease” Actually Mean?
The language surrounding vaccine approvals deserves scrutiny.
Regulators commonly use terms such as “influenza disease” because the regulatory endpoint is the disease outcome being measured in clinical trials. That does not, by itself, mean the vaccine causes influenza or that regulators are deliberately redefining vaccine injuries as influenza.
But language matters, particularly when the public is being asked to make medical decisions.
People deserve to know exactly what a vaccine was tested to prevent, what it was not designed to prevent, how many people were studied, what adverse events occurred, and what remains unknown.
We learned during COVID-19 that public confidence can collapse when people believe important information is being withheld or communicated selectively.
That lesson should not be forgotten.
Zero Day and the Super-Shedder Question
Zero day is the moment your neighbor, your cashier, and your grandmother all roll up their sleeves in the same week.
Critics of mRNA technology fear that widespread vaccination could create an unprecedented exposure scenario. The phrase “super-shedder” has become part of that argument.
But there is an important distinction that must be made.
Traditional vaccine shedding is a recognized phenomenon with certain live attenuated vaccines, where a weakened virus can replicate and potentially be shed. That mechanism is fundamentally different from an injected mRNA vaccine. There is currently no established evidence that people receiving an injected mRNA influenza vaccine become contagious sources of vaccine-derived influenza virus.
That does not mean every question about the technology should be dismissed.
It means the questions need to be answered scientifically rather than assumed in advance.
What happens to the mRNA and lipid nanoparticles after injection? How long do vaccine components persist? What proteins are produced, in which tissues, and for how long? What happens in people with particular medical vulnerabilities? What adverse effects emerge after millions of doses rather than tens of thousands of trial participants?
Those are legitimate questions.
And the public deserves legitimate answers.
Why the Elderly? Follow the Money
Why target adults 50 and older?
The official answer is straightforward: older adults face greater risks from influenza, making them an important population for influenza prevention. The clinical program was specifically designed to evaluate the vaccine in this age group, and Moderna’s pivotal study included more than 40,000 participants.
But critics see another side of the equation.
Older Americans represent a massive healthcare market involving Medicare, prescription drugs, hospitals, long-term care, and chronic disease management. That does not prove that anyone is attempting to harm or eliminate the elderly. Such a claim would require extraordinary evidence.
Still, follow the money remains a reasonable investigative principle.
Whenever billions of dollars are involved in a new medical technology, Americans should ask who profits, who assumes the risk, who regulates the manufacturers, and what happens if unexpected problems emerge years later.
Those questions are not conspiracy theories.
They are questions of accountability.
The Bigger Issue: Trust
The real crisis may not be the mRNA flu vaccine itself.
It may be the collapse of public trust.
Millions of Americans remember being told during the COVID era that certain questions were settled, only to watch recommendations, mandates, definitions, and public-health messaging change repeatedly.
That experience left a large segment of the population skeptical of government health agencies and pharmaceutical companies.
Now the same basic technology is moving into influenza.
That means regulators have an enormous responsibility.
They must disclose the data.
They must acknowledge uncertainty.
They must aggressively investigate adverse events.
They must continue monitoring recipients after approval.
And they must resist the temptation to label every skeptical question as misinformation.
Protect Yourself Before Zero Day Arrives
Since you cannot walk into a store and identify who has received an mRNA vaccine, the rational approach is not panic. It is preparation.
That means maintaining good general health, getting adequate sleep, eating a nutritious diet, exercising appropriately, spending time outdoors, and discussing individual vaccination decisions with a qualified healthcare professional who understands your medical history.
Claims about specific supplements being able to “clear spike protein” or eliminate lipid nanoparticles should also be treated cautiously. There is no established nutritional protocol proven to remove vaccine components from the body or prevent alleged vaccine shedding.
The bigger principle remains simple:
Do not surrender your health decisions to fear.
Ask questions.
Read the clinical data.
Look at the adverse-event information.
Understand what the FDA actually approved.
Understand what remains unknown.
And make medical decisions based on evidence rather than pressure from either government agencies or internet personalities.
The Prophetic Warning: Technology Without Accountability
There is also a deeper lesson here.
Scripture repeatedly warns about human beings placing ultimate trust in earthly systems rather than God. Technology itself is not evil. Medicine is not evil. Scientific discovery is not evil.
But technological power without moral accountability can become dangerous.
The warning is not that every new medical technology represents biblical prophecy.
The warning is that mankind should never assume that because something can be engineered, it automatically should be deployed without humility, transparency, and accountability.
As medical technology becomes increasingly sophisticated, Christians should remain watchful without allowing fear to replace discernment.
“Test all things; hold fast what is good.” — 1 Thessalonians 5:21
Zero day, in the cybersecurity sense, represents an unknown vulnerability.
The lesson for society is similar: identify vulnerabilities before they become disasters.
And when a new medical platform reaches millions of people, Americans have every right to demand that safety questions be answered before—not after—the damage is done.
The Bottom Line
The FDA’s approval of Moderna’s mRNA influenza vaccine is unquestionably a major development in the history of vaccine technology. It is the first U.S.-approved mRNA vaccine specifically for seasonal influenza, and it is being introduced for adults 50 and older.
Whether it ultimately represents a breakthrough or another chapter in the controversy surrounding mRNA technology will depend on what happens after widespread use.
The public should not be told to blindly trust.
But neither should people be told that unproven claims are established facts.
Watch the data. Watch the adverse-event reports. Watch the regulatory decisions. And above all, stay informed.
The questions surrounding this technology are not going away.
Neither should the public’s demand for answers.
Frequently Asked Questions
Is Moderna’s mRNA flu vaccine approved?
Yes. The FDA approved Moderna’s mFLUSIVA for adults 50 and older in August 2026.
Is mFLUSIVA the first mRNA flu vaccine approved in the United States?
Yes. It is the first mRNA-based seasonal influenza vaccine approved by the FDA.
Does an injected mRNA vaccine shed live influenza virus?
There is no established evidence that injected mRNA influenza vaccines shed live vaccine virus. Vaccine-virus shedding is associated with certain live attenuated vaccines and involves a different biological mechanism.
What ages can receive mFLUSIVA?
The FDA approved it for adults 50 and older, with traditional approval for ages 50–64 and accelerated approval for those 65 and older.
Should people be concerned about mRNA vaccine safety?
People should review the available evidence, understand the known risks and benefits, and discuss individual circumstances with a qualified healthcare professional before making a medical decision.
After much research, the following supplements can prevent Covid and other viruses. My family and I mainly follow the protocol of Dr Bryan Ardis. This is only my opinion based on my own family’s success. Please make sure you do your own research and speak with your medical professional before making any changes to your health routine.
EDTA
Glutathion
NAC
Zinc
Vitamin C (Ascorbic Acid)
Vitamin D3
Quercetin
Cats Claw
Nicotine
Bromelain
Curcumin
Dr. McCullough recommends taking this treatment triad for at least three months for anyone suffering from or worried about post-COVID or post-vaccine syndromes.
Nattokinase, Bromelain, and Curcumin are available over the counter at just about any health food store or pharmacy.
Selenium
Dandelion Root
Black Sativa Extract (may facilitate cellular repair)
Green Tea Extract (provides added defenses at the cellular level through scavenging for free radicals)
Irish Sea Moss (could help rebuild damaged tissue and muscle)
In an acute emergency, if you get Covid, Dr Ardis suggests taking low doses of Nicotine in the form of Lozenges, Gum, or Patches for a few days until symptoms subside
Affiliate Disclosure:
Some links in my articles may bring me a small commission at no extra cost to you. Thank you for your support of my work here!
Leave a comment